AnalystsLaura PrendergastLaura Prendergast's Stock Forecasts
AnalystsLaura Prendergast
Sectors:
Industries:
Analyst Ranking
Bottom 11%
#4587 out of 5096 analysts
Average Return
-15.86%
Win Rate
33%4 out of 12
Risk vs Reward
Poor
Good
Laura Prendergast's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Erasca IncERAS | +53.38% | $1.48 | $2.27 | 2025-03-25 - 2025-11-07 | Buy |
Revolution Medicines IncRVMD | +45.95% | $27.38 | $39.96 | 2024-01-15 - 2025-01-15 | Buy |
Revolution Medicines IncRVMD | +22.81% | $49.68 | $61.01 | 2025-10-15 - 2025-11-07 | Strong Buy |
Nuvalent IncNUVL | +3.24% | $90.42 | $93.35 | 2025-10-15 - 2025-11-07 | Strong Buy |
Laura Prendergast Analyst Color
Get additional color on Laura Prendergast's coverage of popular stocks
Laura Prendergast's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nuvalent IncNUVL | 1 | Strong Buy | $115.00 | +23.19% | Reinstates | 23 days ago |
Black Diamond Therapeutics IncBDTX | 2 | Strong Buy | $8.00 | +105.66% | Reinstates | 23 days ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $85.00 | +39.32% | Reinstates | 23 days ago |
Erasca IncERAS | 2 | Strong Buy | $4.00 | +76.21% | Initiates Coverage On | 23 days ago |
Cogent Biosciences IncCOGT | 1 | Hold | $16.00 | +7.96% | Initiates Coverage On | 23 days ago |
Mural Oncology PLCMURA | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Nkarta IncNKTX | 2 | Strong Buy | $16.00 | N/A | Upgrades | a year ago |
Third Harmonic Bio IncTHRD | 1 | Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.